Cargando…
Complement Activation and Regulation in Preeclamptic Placenta
Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regula...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088925/ https://www.ncbi.nlm.nih.gov/pubmed/25071773 http://dx.doi.org/10.3389/fimmu.2014.00312 |
_version_ | 1782325056891781120 |
---|---|
author | Lokki, Anna Inkeri Heikkinen-Eloranta, Jenni Jarva, Hanna Saisto, Terhi Lokki, Marja-Liisa Laivuori, Hannele Meri, Seppo |
author_facet | Lokki, Anna Inkeri Heikkinen-Eloranta, Jenni Jarva, Hanna Saisto, Terhi Lokki, Marja-Liisa Laivuori, Hannele Meri, Seppo |
author_sort | Lokki, Anna Inkeri |
collection | PubMed |
description | Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regulators in placentae were analyzed. Cryostat sections of placentae were processed from 7 early-onset PE (diagnosis <34 weeks of gestation), 5 late-onset PE, 10 control pregnancies, and immunostained for 6 complement activators and 6 inhibitors. Fluorescence was quantified and compared between PE and control placentae. Gene copy numbers of complement components C4A and C4B were assessed by a quantitative PCR method. Maternal C4 deficiencies (≥1 missing or non-functional C4) were most common in the early-onset PE group (71%), and more frequent in late-onset PE compared to healthy controls (60 vs. 38%). Complement C1q deposition differed significantly between control and patient groups: controls and early-onset PE patients had more C1q than late-onset PE patients (mean p = 0.01 and p = 0.005, respectively). C3 activation was analyzed by staining for C3b/iC3b and C3d. C3d was mostly specific to the basal syncytium and C3b/iC3b diffuse in other structures, but there were no clear differences between the study groups. Activated C4 and membrane-bound regulators CD55, CD46, and CD59 were observed abundantly in the syncytiotrophoblast. Syncytial knots, structures enriched in PE, stained specifically for the classical pathway inhibitor C4bp, whereas the key regulator alternative pathway, factor H (FH) showed a wider distribution in the placenta. Differences in C1q deposition between late- and early-onset PE groups may be indicative of the different etiology of PE symptoms in these patients. Irregular distribution of the complement regulators C4bp and FH in the PE placenta and a higher frequency of C4A deficiencies suggest a disturbed balance between complement activation and regulation in PE. |
format | Online Article Text |
id | pubmed-4088925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-40889252014-07-28 Complement Activation and Regulation in Preeclamptic Placenta Lokki, Anna Inkeri Heikkinen-Eloranta, Jenni Jarva, Hanna Saisto, Terhi Lokki, Marja-Liisa Laivuori, Hannele Meri, Seppo Front Immunol Immunology Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regulators in placentae were analyzed. Cryostat sections of placentae were processed from 7 early-onset PE (diagnosis <34 weeks of gestation), 5 late-onset PE, 10 control pregnancies, and immunostained for 6 complement activators and 6 inhibitors. Fluorescence was quantified and compared between PE and control placentae. Gene copy numbers of complement components C4A and C4B were assessed by a quantitative PCR method. Maternal C4 deficiencies (≥1 missing or non-functional C4) were most common in the early-onset PE group (71%), and more frequent in late-onset PE compared to healthy controls (60 vs. 38%). Complement C1q deposition differed significantly between control and patient groups: controls and early-onset PE patients had more C1q than late-onset PE patients (mean p = 0.01 and p = 0.005, respectively). C3 activation was analyzed by staining for C3b/iC3b and C3d. C3d was mostly specific to the basal syncytium and C3b/iC3b diffuse in other structures, but there were no clear differences between the study groups. Activated C4 and membrane-bound regulators CD55, CD46, and CD59 were observed abundantly in the syncytiotrophoblast. Syncytial knots, structures enriched in PE, stained specifically for the classical pathway inhibitor C4bp, whereas the key regulator alternative pathway, factor H (FH) showed a wider distribution in the placenta. Differences in C1q deposition between late- and early-onset PE groups may be indicative of the different etiology of PE symptoms in these patients. Irregular distribution of the complement regulators C4bp and FH in the PE placenta and a higher frequency of C4A deficiencies suggest a disturbed balance between complement activation and regulation in PE. Frontiers Media S.A. 2014-07-09 /pmc/articles/PMC4088925/ /pubmed/25071773 http://dx.doi.org/10.3389/fimmu.2014.00312 Text en Copyright © 2014 Lokki, Heikkinen-Eloranta, Jarva, Saisto, Lokki, Laivuori and Meri. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lokki, Anna Inkeri Heikkinen-Eloranta, Jenni Jarva, Hanna Saisto, Terhi Lokki, Marja-Liisa Laivuori, Hannele Meri, Seppo Complement Activation and Regulation in Preeclamptic Placenta |
title | Complement Activation and Regulation in Preeclamptic Placenta |
title_full | Complement Activation and Regulation in Preeclamptic Placenta |
title_fullStr | Complement Activation and Regulation in Preeclamptic Placenta |
title_full_unstemmed | Complement Activation and Regulation in Preeclamptic Placenta |
title_short | Complement Activation and Regulation in Preeclamptic Placenta |
title_sort | complement activation and regulation in preeclamptic placenta |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088925/ https://www.ncbi.nlm.nih.gov/pubmed/25071773 http://dx.doi.org/10.3389/fimmu.2014.00312 |
work_keys_str_mv | AT lokkiannainkeri complementactivationandregulationinpreeclampticplacenta AT heikkinenelorantajenni complementactivationandregulationinpreeclampticplacenta AT jarvahanna complementactivationandregulationinpreeclampticplacenta AT saistoterhi complementactivationandregulationinpreeclampticplacenta AT lokkimarjaliisa complementactivationandregulationinpreeclampticplacenta AT laivuorihannele complementactivationandregulationinpreeclampticplacenta AT meriseppo complementactivationandregulationinpreeclampticplacenta |